Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 17-Apr-24 5:19 PM View:  | Baroldi Joseph EVP, Chief Business Officer | ISIS Pharmaceuticals Inc. (IONS) | 16-Apr-24 | Option Sale | 4,006 | $41.60 | $166,641.00 | (16%) 25.28K to 21.27K | |
| 17-Apr-24 5:16 PM View: | Birchler Brian EVP, Corp and Development Ops | ISIS Pharmaceuticals Inc. (IONS) | 16-Apr-24 | Option Sale | 905 | $41.66 | $37,698.20 | (2%) 47.06K to 46.16K | |
| 17-Apr-24 5:19 PM View: | Baroldi Joseph EVP, Chief Business Officer | ISIS Pharmaceuticals Inc. (IONS) | 15-Apr-24 | Option Exercise | 10,838 | -- | -- | 75% 14.44K to 25.28K | |
| 17-Apr-24 5:16 PM View: | Birchler Brian EVP, Corp and Development Ops | ISIS Pharmaceuticals Inc. (IONS) | 15-Apr-24 | Option Exercise | 1,875 | -- | -- | 4% 45.19K to 47.06K | |
| 04-Mar-24 7:13 PM View: | Geary Richard S Officer Level 14 | ISIS Pharmaceuticals Inc. (IONS) | 29-Feb-24 | Acquisition (other) | 604 | $34.42 | $20,792.70 | < 1% 87.33K to 87.94K | |
| 04-Mar-24 7:13 PM View: | Bennett C Frank Officer Level 14 | ISIS Pharmaceuticals Inc. (IONS) | 29-Feb-24 | Acquisition (other) | 383 | $34.42 | $13,184.80 | < 1% 79.08K to 79.46K | |
| 04-Mar-24 7:13 PM View: | Monia Brett P CEO Level 15 Director | ISIS Pharmaceuticals Inc. (IONS) | 29-Feb-24 | Acquisition (other) | 538 | $34.42 | $18,520.70 | < 1% 173.75K to 174.29K | |
| 04-Mar-24 7:13 PM View: | Birchler Brian Vice President Level 14 | ISIS Pharmaceuticals Inc. (IONS) | 29-Feb-24 | Acquisition (other) | 604 | $34.42 | $20,792.70 | 1% 44.58K to 45.19K | |
| 04-Mar-24 7:13 PM View: | Swayze Eric Officer Level 14 | ISIS Pharmaceuticals Inc. (IONS) | 29-Feb-24 | Acquisition (other) | 605 | $34.42 | $20,827.10 | 2% 34.41K to 35.01K | |
| 16-Feb-24 7:47 PM View: | Monia Brett P Chief Executive Officer Director | ISIS Pharmaceuticals Inc. (IONS) | 16-Feb-24 | Private Sale | 387 | $44.49 | $17,218.60 | (< 1%) 174.14K to 173.75K | |
| 02-Feb-24 7:54 PM View: | Geary Richard S EVP, Chief Development Officer | ISIS Pharmaceuticals Inc. (IONS) | 02-Feb-24 | Sale | 1,961 | $50.04 | $98,134.90 | (2%) 89.3K to 87.33K | |
| 02-Feb-24 7:54 PM View: | Bennett C Frank EVP, Chief Scientific Officer | ISIS Pharmaceuticals Inc. (IONS) | 02-Feb-24 | Sale | 1,853 | $49.52 | $91,752.40 | (2%) 80.93K to 79.08K | |
| 02-Feb-24 7:54 PM View: | Cadoret-Manier Onaiza EVP, Chf GL Pdt Str & Oper Ofc | ISIS Pharmaceuticals Inc. (IONS) | 02-Feb-24 | Sale | 2,125 | $49.60 | $105,404.00 | (6%) 37.95K to 35.83K | |
| 02-Feb-24 7:55 PM View: | Monia Brett P Chief Executive Officer Director | ISIS Pharmaceuticals Inc. (IONS) | 02-Feb-24 | Sale | 23,501 | $49.37 | $1,160,300.00 | (12%) 197.64K to 174.14K | |
| 02-Feb-24 7:55 PM View: | O'Neil Patrick R. EVP CLO & General Counsel | ISIS Pharmaceuticals Inc. (IONS) | 02-Feb-24 | Sale | 1,961 | $49.67 | $97,410.30 | (4%) 50.62K to 48.66K | |
| 02-Feb-24 7:55 PM View: | Schneider Eugene EVP, Chf Clinical Develop Ofcr | ISIS Pharmaceuticals Inc. (IONS) | 02-Feb-24 | Sale | 2,071 | $49.59 | $102,701.00 | (4%) 51.88K to 49.81K | |
| 02-Feb-24 7:55 PM View: | Hougen Elizabeth L EVP, Finance & CFO | ISIS Pharmaceuticals Inc. (IONS) | 02-Feb-24 | Sale | 2,125 | $49.54 | $105,272.00 | (2%) 95.03K to 92.91K | |
| 02-Feb-24 7:55 PM View: | Swayze Eric EVP Research | ISIS Pharmaceuticals Inc. (IONS) | 02-Feb-24 | Sale | 1,907 | $49.56 | $94,513.40 | (5%) 36.32K to 34.41K | |
| 02-Feb-24 7:55 PM View: | Swayze Eric EVP Research | ISIS Pharmaceuticals Inc. (IONS) | 01-Feb-24 | Grant | 3,715 | -- | -- | 11% 32.6K to 36.32K | |
| 02-Feb-24 7:55 PM View: | Schneider Eugene EVP, Chf Clinical Develop Ofcr | ISIS Pharmaceuticals Inc. (IONS) | 01-Feb-24 | Grant | 4,033 | -- | -- | 8% 47.85K to 51.88K | |
| 02-Feb-24 7:55 PM View: | Hougen Elizabeth L EVP, Finance & CFO | ISIS Pharmaceuticals Inc. (IONS) | 01-Feb-24 | Grant | 4,140 | -- | -- | 5% 90.89K to 95.03K | |
| 02-Feb-24 7:55 PM View: | Monia Brett P Chief Executive Officer Director | ISIS Pharmaceuticals Inc. (IONS) | 01-Feb-24 | Grant | 45,788 | -- | -- | 30% 151.85K to 197.64K | |
| 02-Feb-24 7:55 PM View: | O'Neil Patrick R. EVP CLO & General Counsel | ISIS Pharmaceuticals Inc. (IONS) | 01-Feb-24 | Grant | 3,820 | -- | -- | 8% 46.8K to 50.62K | |
| 02-Feb-24 7:54 PM View: | Geary Richard S EVP, Chief Development Officer | ISIS Pharmaceuticals Inc. (IONS) | 01-Feb-24 | Grant | 3,820 | -- | -- | 4% 85.47K to 89.3K | |
| 02-Feb-24 7:54 PM View: | Bennett C Frank EVP, Chief Scientific Officer | ISIS Pharmaceuticals Inc. (IONS) | 01-Feb-24 | Grant | 3,609 | -- | -- | 5% 77.32K to 80.93K | |
| 02-Feb-24 7:54 PM View: | Cadoret-Manier Onaiza EVP, Chf GL Pdt Str & Oper Ofc | ISIS Pharmaceuticals Inc. (IONS) | 01-Feb-24 | Grant | 4,140 | -- | -- | 12% 33.81K to 37.95K | |
| 02-Feb-24 7:55 PM View: | Swayze Eric EVP Research | ISIS Pharmaceuticals Inc. (IONS) | 31-Jan-24 | Private Sale | 10,773 | $52.00 | $560,196.00 | (25%) 43.37K to 32.6K | |
| 29-Jan-24 5:34 PM View: | O'Neil Patrick R. EVP CLO & General Counsel | ISIS Pharmaceuticals Inc. (IONS) | 25-Jan-24 | Private Sale | 6,450 | $51.75 | $333,788.00 | (12%) 53.25K to 46.8K | |
| 29-Jan-24 5:34 PM View: | Monia Brett P Chief Executive Officer Director | ISIS Pharmaceuticals Inc. (IONS) | 25-Jan-24 | Private Sale | 2,285 | $51.75 | $118,249.00 | (1%) 154.14K to 151.85K | |
| 18-Jan-24 5:48 PM View: | Schneider Eugene EVP, Chf Clinical Develop Ofcr | ISIS Pharmaceuticals Inc. (IONS) | 17-Jan-24 | Option Sale | 5,482 | $50.42 | $276,386.00 | (10%) 53.33K to 47.85K | |
| 18-Jan-24 5:48 PM View: | Hougen Elizabeth L EVP, Finance & CFO | ISIS Pharmaceuticals Inc. (IONS) | 17-Jan-24 | Option Sale | 8,683 | $50.42 | $437,771.00 | (9%) 99.57K to 90.89K | |
| 18-Jan-24 5:48 PM View: | Monia Brett P Chief Executive Officer Director | ISIS Pharmaceuticals Inc. (IONS) | 17-Jan-24 | Option Sale | 32,059 | $50.42 | $1,616,320.00 | (17%) 186.19K to 154.14K | |
| 18-Jan-24 5:59 PM View: | O'Neil Patrick R. EVP CLO & General Counsel | ISIS Pharmaceuticals Inc. (IONS) | 17-Jan-24 | Option Sale | 7,744 | $50.42 | $390,429.00 | (13%) 61.0K to 53.25K | |
| 18-Jan-24 5:44 PM View: | Baroldi Joseph EVP, Chief Business Officer | ISIS Pharmaceuticals Inc. (IONS) | 17-Jan-24 | Option Sale | 1,460 | $50.42 | $73,608.80 | (9%) 16.46K to 15.0K | |
| 18-Jan-24 5:55 PM View: | Birchler Brian EVP, Corp and Development Ops | ISIS Pharmaceuticals Inc. (IONS) | 17-Jan-24 | Option Sale | 4,497 | $50.42 | $226,725.00 | (9%) 49.08K to 44.58K | |
| 18-Jan-24 5:47 PM View: | Geary Richard S EVP, Chief Development Officer | ISIS Pharmaceuticals Inc. (IONS) | 17-Jan-24 | Option Sale | 7,338 | $50.42 | $369,960.00 | (8%) 92.81K to 85.47K | |
| 18-Jan-24 5:44 PM View: | Bennett C Frank EVP, Chief Scientific Officer | ISIS Pharmaceuticals Inc. (IONS) | 17-Jan-24 | Option Sale | 6,745 | $50.42 | $340,063.00 | (8%) 84.07K to 77.32K | |
| 18-Jan-24 5:49 PM View: | Swayze Eric EVP Research | ISIS Pharmaceuticals Inc. (IONS) | 17-Jan-24 | Option Sale | 6,296 | $50.42 | $317,425.00 | (13%) 49.68K to 43.38K | |
| 18-Jan-24 6:07 PM View: | Cadoret-Manier Onaiza EVP, Chf GL Pdt Str & Oper Ofc | ISIS Pharmaceuticals Inc. (IONS) | 17-Jan-24 | Option Sale | 5,564 | $50.42 | $280,520.00 | (14%) 39.37K to 33.81K | |
| 18-Jan-24 5:44 PM View: | Baroldi Joseph EVP, Chief Business Officer | ISIS Pharmaceuticals Inc. (IONS) | 17-Jan-24 | Option Sale | 564 | $50.42 | $28,435.20 | (4%) 15.0K to 14.44K | |
| 18-Jan-24 5:49 PM View: | Swayze Eric EVP Research | ISIS Pharmaceuticals Inc. (IONS) | 17-Jan-24 | Option Sale | 9 | $50.42 | $453.75 | (< 1%) 43.38K to 43.37K | |
| 18-Jan-24 5:55 PM View: | Birchler Brian EVP, Corp and Development Ops | ISIS Pharmaceuticals Inc. (IONS) | 16-Jan-24 | Option Exercise | 12,080 | -- | -- | 33% 37.0K to 49.08K | |
| 18-Jan-24 5:47 PM View: | Geary Richard S EVP, Chief Development Officer | ISIS Pharmaceuticals Inc. (IONS) | 16-Jan-24 | Option Exercise | 19,852 | -- | -- | 27% 72.96K to 92.81K | |
| 18-Jan-24 5:44 PM View: | Bennett C Frank EVP, Chief Scientific Officer | ISIS Pharmaceuticals Inc. (IONS) | 16-Jan-24 | Option Exercise | 18,314 | -- | -- | 28% 65.75K to 84.07K | |
| 18-Jan-24 5:48 PM View: | Schneider Eugene EVP, Chf Clinical Develop Ofcr | ISIS Pharmaceuticals Inc. (IONS) | 16-Jan-24 | Option Exercise | 15,162 | -- | -- | 40% 38.17K to 53.33K | |
| 18-Jan-24 6:07 PM View: | Cadoret-Manier Onaiza EVP, Chf GL Pdt Str & Oper Ofc | ISIS Pharmaceuticals Inc. (IONS) | 16-Jan-24 | Option Exercise | 15,062 | -- | -- | 62% 24.31K to 39.37K | |
| 18-Jan-24 5:49 PM View: | Swayze Eric EVP Research | ISIS Pharmaceuticals Inc. (IONS) | 16-Jan-24 | Option Exercise | 17,069 | -- | -- | 52% 32.59K to 49.66K | |
| 18-Jan-24 5:59 PM View: | O'Neil Patrick R. EVP CLO & General Counsel | ISIS Pharmaceuticals Inc. (IONS) | 16-Jan-24 | Option Exercise | 20,641 | -- | -- | 51% 40.35K to 61.0K | |
| 18-Jan-24 5:44 PM View: | Baroldi Joseph EVP, Chief Business Officer | ISIS Pharmaceuticals Inc. (IONS) | 16-Jan-24 | Option Exercise | 3,688 | -- | -- | 32% 11.42K to 15.11K | |
| 18-Jan-24 5:48 PM View: | Hougen Elizabeth L EVP, Finance & CFO | ISIS Pharmaceuticals Inc. (IONS) | 16-Jan-24 | Option Exercise | 22,487 | -- | -- | 29% 77.09K to 99.57K |
